Literature DB >> 24726477

Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-human trial.

Ilario Fulco1, Sylvie Miot1, Martin D Haug2, Andrea Barbero1, Anke Wixmerten1, Sandra Feliciano1, Francine Wolf1, Gernot Jundt3, Anna Marsano1, Jian Farhadi4, Michael Heberer1, Marcel Jakob1, Dirk J Schaefer1, Ivan Martin5.   

Abstract

BACKGROUND: Autologous native cartilage from the nasal septum, ear, or rib is the standard material for surgical reconstruction of the nasal alar lobule after two-layer excision of non-melanoma skin cancer. We assessed whether engineered autologous cartilage grafts allow safe and functional alar lobule restoration.
METHODS: In a first-in-human trial, we recruited five patients at the University Hospital Basel (Basel, Switzerland). To be eligible, patients had to be aged at least 18 years and have a two-layer defect (≥50% size of alar subunit) after excision of non-melanoma skin cancer on the alar lobule. Chondrocytes (isolated from a 6 mm cartilage biopsy sample from the nasal septum harvested under local anaesthesia during collection of tumour biopsy sample) were expanded, seeded, and cultured with autologous serum onto collagen type I and type III membranes in the course of 4 weeks. The resulting engineered cartilage grafts (25 mm × 25 mm × 2 mm) were shaped intra-operatively and implanted after tumour excision under paramedian forehead or nasolabial flaps, as in standard reconstruction with native cartilage. During flap refinement after 6 months, we took biopsy samples of repair tissues and histologically analysed them. The primary outcomes were safety and feasibility of the procedure, assessed 12 months after reconstruction. At least 1 year after implantation, when reconstruction is typically stabilised, we assessed patient satisfaction and functional outcomes (alar cutaneous sensibility, structural stability, and respiratory flow rate).
FINDINGS: Between Dec 13, 2010, and Feb 6, 2012, we enrolled two women and three men aged 76-88 years. All engineered grafts contained a mixed hyaline and fibrous cartilage matrix. 6 months after implantation, reconstructed tissues displayed fibromuscular fatty structures typical of the alar lobule. After 1 year, all patients were satisfied with the aesthetic and functional outcomes and no adverse events had been recorded. Cutaneous sensibility and structural stability of the reconstructed area were clinically satisfactory, with adequate respiratory function.
INTERPRETATION: Autologous nasal cartilage tissues can be engineered and clinically used for functional restoration of alar lobules. Engineered cartilage should now be assessed for other challenging facial reconstructions. FUNDING: Foundation of the Department of Surgery, University Hospital Basel; and Krebsliga beider Basel.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24726477     DOI: 10.1016/S0140-6736(14)60544-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  How far are we from repairing cartilage tissue with tissue-engineered products?: 'An Editorial for Bioreactor manufactured cartilage grafts repair acute and chronic osteochondral defects in large animal studies: doi:10.1111/cpr.12653'.

Authors:  Ling Wu
Journal:  Cell Prolif       Date:  2019-08-16       Impact factor: 6.831

Review 2.  Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.

Authors:  Juan M Colazo; Brian C Evans; Angel F Farinas; Salam Al-Kassis; Craig L Duvall; Wesley P Thayer
Journal:  Tissue Eng Part B Rev       Date:  2019-08       Impact factor: 6.389

3.  Advancing biomaterials of human origin for tissue engineering.

Authors:  Fa-Ming Chen; Xiaohua Liu
Journal:  Prog Polym Sci       Date:  2015-03-28       Impact factor: 29.190

4.  A photo-crosslinkable cartilage-derived extracellular matrix bioink for auricular cartilage tissue engineering.

Authors:  Dafydd O Visscher; Hyeongjin Lee; Paul P M van Zuijlen; Marco N Helder; Anthony Atala; James J Yoo; Sang Jin Lee
Journal:  Acta Biomater       Date:  2020-11-21       Impact factor: 8.947

5.  Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation.

Authors:  M Caralt; J S Uzarski; S Iacob; K P Obergfell; N Berg; B M Bijonowski; K M Kiefer; H H Ward; A Wandinger-Ness; W M Miller; Z J Zhang; M M Abecassis; J A Wertheim
Journal:  Am J Transplant       Date:  2014-11-17       Impact factor: 8.086

6.  Oxygen Delivering Biomaterials for Tissue Engineering.

Authors:  Ashley L Farris; Alexandra N Rindone; Warren L Grayson
Journal:  J Mater Chem B       Date:  2016-02-22       Impact factor: 6.331

7.  Ear-Shaped Stable Auricular Cartilage Engineered from Extensively Expanded Chondrocytes in an Immunocompetent Experimental Animal Model.

Authors:  Irina Pomerantseva; David A Bichara; Alan Tseng; Michael J Cronce; Thomas M Cervantes; Anya M Kimura; Craig M Neville; Nick Roscioli; Joseph P Vacanti; Mark A Randolph; Cathryn A Sundback
Journal:  Tissue Eng Part A       Date:  2015-12-15       Impact factor: 3.845

8.  Evaluation of Autogenous Engineered Septal Cartilage Grafts in Rabbits- A Minimally Invasive Preclinical Model.

Authors:  Anton Kushnaryov; Tomonoro Yamaguchi; Kristen K Briggs; Van W Wong; Marsha Reuther; Monica Neuman; Victor Lin; Robert L Sah; Koichi Masuda; Deborah Watson
Journal:  Adv Otolaryngol       Date:  2014-07-23

Review 9.  Three-Dimensional Bioprinting Scaffolding for Nasal Cartilage Defects: A Systematic Review.

Authors:  Carlos M Chiesa-Estomba; Ana Aiastui; Iago González-Fernández; Raquel Hernáez-Moya; Claudia Rodiño; Alba Delgado; Juan P Garces; Jacobo Paredes-Puente; Javier Aldazabal; Xabier Altuna; Ander Izeta
Journal:  Tissue Eng Regen Med       Date:  2021-04-17       Impact factor: 4.169

10.  [In vitro regeneration of tissue engineered cartilage and its clinical application for nasal reconstruction].

Authors:  Pengjie Ren; Yihao Xu; Fei Fan; Le Tian; Xiaona Lu; Jianjun You; Huan Wang; Ruobing Zheng
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.